Technical Analysis for PRTK - Paratek Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 3.35 -0.59% -0.02
PRTK closed down 0.59 percent on Friday, November 15, 2019, on 45 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Dec 1

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical PRTK trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -0.59%
Wide Bands Range Expansion -0.59%
Fell Below 50 DMA Bearish -9.46%
20 DMA Support Bullish -9.46%

Older signals for PRTK ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Paratek Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of antibiotics to save lives and alleviate suffering. It offers, omadacycline, a tetracycline-derived, broad-spectrum antibiotic for use as a first-line monotherapy for acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, urinary tract infections, and other serious community-acquired bacterial infections. The company also provides WC 3035, a tetracycline-derived compound with dual narrow-spectrum antibacterial and potent anti-inflammatory activity for use in the treatment of acne and rosacea. In addition, it offers solutions for multiple sclerosis, SMS, and RA/IBD. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.
Medicine Biopharmaceutical Clinical Medicine Organ Systems Infection Multiple Sclerosis SMS Antibiotics Acne Antibiotic Hepatotoxins Skin And Skin Structure Infections Community Acquired Bacterial Pneumonia Rosacea Urinary Tract Infections Anti Acne Preparations Ibd
Is PRTK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.65
52 Week Low 2.66
Average Volume 637,934
200-Day Moving Average 4.6549
50-Day Moving Average 3.9604
20-Day Moving Average 3.513
10-Day Moving Average 3.782
Average True Range 0.3808
ADX 17.94
+DI 21.9406
-DI 28.5398
Chandelier Exit (Long, 3 ATRs ) 3.4076
Chandelier Exit (Short, 3 ATRs ) 3.8024
Upper Bollinger Band 4.2953
Lower Bollinger Band 2.7307
Percent B (%b) 0.4
BandWidth 44.537432
MACD Line -0.0115
MACD Signal Line -0.0307
MACD Histogram 0.0192
Fundamentals Value
Market Cap 93 Million
Num Shares 27.8 Million
EPS -3.95
Price-to-Earnings (P/E) Ratio -0.85
Price-to-Sales 77.65
Price-to-Book 5.15
PEG Ratio -0.02
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.62
Resistance 3 (R3) 3.63 3.56 3.58
Resistance 2 (R2) 3.56 3.49 3.55 3.56
Resistance 1 (R1) 3.45 3.45 3.42 3.44 3.54
Pivot Point 3.38 3.38 3.36 3.37 3.38
Support 1 (S1) 3.27 3.31 3.24 3.26 3.16
Support 2 (S2) 3.20 3.27 3.19 3.14
Support 3 (S3) 3.09 3.20 3.13
Support 4 (S4) 3.08